140 related articles for article (PubMed ID: 17997573)
1. Stereoselective synthesis of a MCHr1 antagonist.
Andersen D; Storz T; Liu P; Wang X; Li L; Fan P; Chen X; Allgeier A; Burgos A; Tedrow J; Baum J; Chen Y; Crockett R; Huang L; Syed R; Larsen RD; Martinelli M
J Org Chem; 2007 Dec; 72(25):9648-55. PubMed ID: 17997573
[TBL] [Abstract][Full Text] [Related]
2. Anti-obesity effects of small molecule melanin-concentrating hormone receptor 1 (MCHR1) antagonists.
Luthin DR
Life Sci; 2007 Jul; 81(6):423-40. PubMed ID: 17655875
[TBL] [Abstract][Full Text] [Related]
3. Biological examination of melanin concentrating hormone receptor 1: multi-tasking from the hypothalamus.
Rokosz LL; Hobbs DW
Drug News Perspect; 2006 Jun; 19(5):273-86. PubMed ID: 16941049
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of urea-based indazoles as melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity.
Souers AJ; Gao J; Wodka D; Judd AS; Mulhern MM; Napier JJ; Brune ME; Bush EN; Brodjian SJ; Dayton BD; Shapiro R; Hernandez LE; Marsh KC; Sham HL; Collins CA; Kym PR
Bioorg Med Chem Lett; 2005 Jun; 15(11):2752-7. PubMed ID: 15911251
[TBL] [Abstract][Full Text] [Related]
5. Building a MCHR1 homology model provides insight into the receptor-antagonist contacts that are important for the development of new anti-obesity agents.
Cirauqui N; Schrey AK; Galiano S; Ceras J; Pérez-Silanes S; Aldana I; Monge A; Kühne R
Bioorg Med Chem; 2010 Nov; 18(21):7365-79. PubMed ID: 20932767
[TBL] [Abstract][Full Text] [Related]
6. 6-(4-chlorophenyl)-3-substituted-thieno[3,2-d]pyrimidin-4(3H)-one-based melanin-concentrating hormone receptor 1 antagonist.
Tavares FX; Al-Barazanji KA; Bishop MJ; Britt CS; Carlton DL; Cooper JP; Feldman PL; Garrido DM; Goetz AS; Grizzle MK; Hertzog DL; Ignar DM; Lang DG; McIntyre MS; Ott RJ; Peat AJ; Zhou HQ
J Med Chem; 2006 Nov; 49(24):7108-18. PubMed ID: 17125263
[TBL] [Abstract][Full Text] [Related]
7. Solid-phase synthesis and structure-activity relationships of novel biarylethers as melanin-concentrating hormone receptor-1 antagonists.
Ma V; Bannon AW; Baumgartner J; Hale C; Hsieh F; Hulme C; Rorrer K; Salon J; van Staden C; Tempest P
Bioorg Med Chem Lett; 2006 Oct; 16(19):5066-72. PubMed ID: 16887348
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of 2-amino-8-alkoxy quinolines as MCHr1 antagonists. Part 2.
Vasudevan A; Wodka D; Verzal MK; Souers AJ; Gao J; Brodjian S; Fry D; Dayton B; Marsh KC; Hernandez LE; Ogiela CA; Collins CA; Kym PR
Bioorg Med Chem Lett; 2004 Oct; 14(19):4879-82. PubMed ID: 15341943
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel bicyclo[4.1.0]heptane and bicyclo[3.1.0]hexane derivatives as melanin-concentrating hormone receptor R1 antagonists.
Su J; Tang H; McKittrick BA; Gu H; Guo T; Qian G; Burnett DA; Clader JW; Greenlee WJ; Hawes BE; O'neill K; Spar B; Weig B; Kowalski T; Sorota S
Bioorg Med Chem Lett; 2007 Sep; 17(17):4845-50. PubMed ID: 17604169
[TBL] [Abstract][Full Text] [Related]
10. 4-Aminoquinoline melanin-concentrating hormone 1-receptor (MCH1R) antagonists.
Jiang J; Lin P; Hoang M; Chang L; Tan C; Feighner S; Palyha OC; Hreniuk DL; Pan J; Sailer AW; Morin NR; MacNeil DJ; Howard AD; Van der Ploeg LH; Goulet MT; DeVita RJ
Bioorg Med Chem Lett; 2006 Oct; 16(20):5275-9. PubMed ID: 16919453
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel spiro-piperidine derivatives as highly potent and selective melanin-concentrating hormone 1 receptor antagonists.
Suzuki T; Moriya M; Sakamoto T; Suga T; Kishino H; Takahashi H; Ishikawa M; Nagai K; Imai Y; Sekino E; Ito M; Iwaasa H; Ishihara A; Tokita S; Kanatani A; Sato N; Fukami T
Bioorg Med Chem Lett; 2009 Jun; 19(11):3072-7. PubMed ID: 19403308
[TBL] [Abstract][Full Text] [Related]
12. Identification of substituted 4-aminopiperidines and 3-aminopyrrolidines as potent MCH-R1 antagonists for the treatment of obesity.
Kim N; Meyers KM; Mendez-Andino JL; Warshakoon NC; Ji W; Wos JA; Colson A; Mitchell MC; Davis JR; Pinney BB; Reizes O; Hu XE
Bioorg Med Chem Lett; 2006 Oct; 16(20):5445-50. PubMed ID: 16879961
[TBL] [Abstract][Full Text] [Related]
13. Discovery of 1,3-disubstituted-1H-pyrrole derivatives as potent melanin-concentrating hormone receptor 1 (MCH-R1) antagonists.
Berglund S; Egner BJ; Gradén H; Gradén J; Morgan DG; Inghardt T; Giordanetto F
Bioorg Med Chem Lett; 2008 Sep; 18(17):4859-63. PubMed ID: 18682323
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of 2-amino-8-alkoxy quinolines as MCHr1 antagonists. Part 1.
Souers AJ; Wodka D; Gao J; Lewis JC; Vasudevan A; Gentles R; Brodjian S; Dayton B; Ogiela CA; Fry D; Hernandez LE; Marsh KC; Collins CA; Kym PR
Bioorg Med Chem Lett; 2004 Oct; 14(19):4873-7. PubMed ID: 15341942
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a novel melanin concentrating hormone receptor 1 (MCHR1) antagonist with reduced hERG inhibition.
Mihalic JT; Fan P; Chen X; Chen X; Fu Y; Motani A; Liang L; Lindstrom M; Tang L; Chen JL; Jaen J; Dai K; Li L
Bioorg Med Chem Lett; 2012 Jun; 22(11):3781-5. PubMed ID: 22542010
[TBL] [Abstract][Full Text] [Related]
16. Discovery of potent and stable conformationally constrained analogues of the MCH R1 antagonist SB-568849.
Witty DR; Bateson J; Hervieu GJ; Al-Barazanji K; Jeffrey P; Hamprecht D; Haynes A; Johnson CN; Muir AI; O'Hanlon PJ; Stemp G; Stevens AJ; Thewlis K; Winborn KY
Bioorg Med Chem Lett; 2006 Sep; 16(18):4872-8. PubMed ID: 16839763
[TBL] [Abstract][Full Text] [Related]
17. Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists: part 2.
Sasmal S; Balasubrahmanyam D; Kanna Reddy HR; Balaji G; Srinivas G; Cheera S; Abbineni C; Sasmal PK; Khanna I; Sebastian VJ; Jadhav VP; Singh MP; Talwar R; Suresh J; Shashikumar D; Harinder Reddy K; Sihorkar V; Frimurer TM; Rist Ø; Elster L; Högberg T
Bioorg Med Chem Lett; 2012 May; 22(9):3163-7. PubMed ID: 22497763
[TBL] [Abstract][Full Text] [Related]
18. Biological examination of melanin concentrating hormone receptor 1: multi-tasking from the hypothalamus.
Rokosz LL; Hobbs DW
Timely Top Med Cardiovasc Dis; 2006 Sep; 10():E23. PubMed ID: 17066150
[TBL] [Abstract][Full Text] [Related]
19. Screening for cardiovascular safety: a structure-activity approach for guiding lead selection of melanin concentrating hormone receptor 1 antagonists.
Kym PR; Souers AJ; Campbell TJ; Lynch JK; Judd AS; Iyengar R; Vasudevan A; Gao J; Freeman JC; Wodka D; Mulhern M; Zhao G; Wagaw SH; Napier JJ; Brodjian S; Dayton BD; Reilly RM; Segreti JA; Fryer RM; Preusser LC; Reinhart GA; Hernandez L; Marsh KC; Sham HL; Collins CA; Polakowski JS
J Med Chem; 2006 Apr; 49(7):2339-52. PubMed ID: 16570930
[TBL] [Abstract][Full Text] [Related]
20. The use of three-dimensional shape and electrostatic similarity searching in the identification of a melanin-concentrating hormone receptor 1 antagonist.
Muchmore SW; Souers AJ; Akritopoulou-Zanze I
Chem Biol Drug Des; 2006 Feb; 67(2):174-6. PubMed ID: 16492165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
